Update on Alzheimer's disease - Promising advances in detection and treatment

被引:7
作者
Burke, JR
Morgenlander, JC
机构
[1] Duke Univ, Sch Med, Div Neurol, Durham, NC 27706 USA
[2] Joseph & Kathleen Bryan Alzheimers Dis Res Ctr, Clin Dementia Trials, Durham, NC USA
[3] Deane Lab, Durham, NC USA
[4] Duke Univ, Sch Med, Neurol Residency Training Program, Durham, NC 27706 USA
关键词
D O I
10.3810/pgm.1999.10.15.746
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the past-decade, significant progress has been made in the understanding and treatment of Alzheimer's disease. Modest success has been achieved using new drugs in treatment of mild symptoms of the disease. Vitamin E, estrogen, and NSAIDs may slow the progression of Alzheimer's disease, but their routine use is not without fisk, and there is no evidence that these agents are effective in preventing the disease in asymptomatic people. With our increased understanding of the pathogenesis of Alzheimer's disease, it is likely that the next decade will see further refinement and development of treatment strategies to halt progression and possibly reduce the incidence of disease.
引用
收藏
页码:85 / +
页数:7
相关论文
共 10 条
[1]  
Alzheimers Assoc, 1998, NEUROBIOL AGING, V19, P109
[2]   Alzheimer's disease - Etiologies, pathophysiology, cognitive reserve, and treatment opportunities [J].
Cummings, JL ;
Vinters, HV ;
Cole, GM ;
Khachaturian, ZS .
NEUROLOGY, 1998, 51 (01) :S2-S17
[3]   A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging [J].
Kawas, C ;
Resnick, S ;
Morrison, A ;
Brookmeyer, R ;
Corrada, M ;
Zonderman, A ;
Bacal, C ;
Lingle, DD ;
Metter, E .
NEUROLOGY, 1997, 48 (06) :1517-1521
[4]   Apolipoprotein E and the CNS response to injury [J].
Laskowitz, DT ;
Horsburgh, K ;
Roses, AD .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1998, 18 (05) :465-471
[5]   CLINICAL-TRIAL OF INDOMETHACIN IN ALZHEIMERS-DISEASE [J].
ROGERS, J ;
KIRBY, LC ;
HEMPELMAN, SR ;
BERRY, DL ;
MCGEER, PL ;
KASZNIAK, AW ;
ZALINSKI, J ;
COFIELD, M ;
MANSUKHANI, L ;
WILLSON, P ;
KOGAN, F .
NEUROLOGY, 1993, 43 (08) :1609-1611
[6]   A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease [J].
Rogers, SL ;
Farlow, MR ;
Doody, RS ;
Mohs, R ;
Friedhoff, LT ;
Albala, B ;
Baumel, B ;
Booker, G ;
Dexter, J ;
Farmer, M ;
Feighner, JP ;
Ferris, S ;
Gordon, B ;
Gorman, DG ;
Hanna, G ;
Harrell, LE ;
Hubbard, R ;
Kennedy, J ;
McCarthy, J ;
Scharre, DW ;
Schaerf, F ;
Schneider, L ;
Seltzer, B ;
Siegal, A ;
Stark, SR ;
Strauss, A ;
Walshe, TM .
NEUROLOGY, 1998, 50 (01) :136-145
[7]   A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease [J].
Sano, M ;
Ernesto, C ;
Thomas, RG ;
Klauber, MR ;
Schafer, K ;
Grundman, M ;
Woodbury, P ;
Growdon, J ;
Cotman, DW ;
Pfeiffer, E ;
Schneider, LS ;
Thal, LJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (17) :1216-1222
[8]   Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease [J].
Saunders, AM ;
Hulette, C ;
WelshBohmer, KA ;
Schmechel, DE ;
Crain, B ;
Burke, JR ;
Alberts, MJ ;
Strittmatter, WJ ;
Breitner, JCS ;
Rosenberg, C ;
Scott, SV ;
Gaskell, PC ;
PericakVance, MA ;
Roses, AD .
LANCET, 1996, 348 (9020) :90-93
[9]   Risk of Alzheimer's disease and duration of NSAID use [J].
Stewart, WF ;
Kawas, C ;
Corrada, M ;
Metter, EJ .
NEUROLOGY, 1997, 48 (03) :626-632
[10]   Estrogen therapy in postmenopausal women - Effects on cognitive function and dementia [J].
Yaffe, K ;
Sawaya, G ;
Lieberburg, I ;
Grady, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (09) :688-695